A Test on the Move: Cardiac CT in China as a Case Study

  • Bin Lu
  • Weihua Yin
  • Xinshuang Ren
  • Siyu Chen
Part of the Contemporary Medical Imaging book series (CMI)


With the rapid economic growth and increased life expectancy, China’s population is experiencing rapid transitions; the leading health problems and the challenges imposed on the health system by epidemiological and demographic factors have also changed in recent years. An epidemic of cardiovascular diseases (CVD) in China is emerging as a result of lifestyle changes, urbanization, and the accelerated process of aging. The incidence of CVD is continuously increasing and will remain as an upward trend in the next decades.


The use of cardiac CT in China Cardiovascular disease in China China’s use of cardiac CT Chinese International Regional Committee of the Society of Cardiovascular Computed Tomography People’s Republic of China’s use of cardiac CT 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ministry of Health of the People’s Republic of China. Statistics Year Book of Health of the People’s Republic of China. Beijing: Pecking Union Medical College Press; 2009–2012.Google Scholar
  2. 2.
    National Health and Family Planning Commission of the People’s Republic of China. Year Book of Health and Family Planning in the People’s Republic of China. Beijing: Pecking Union Medical College Press; 2015.Google Scholar
  3. 3.
    Zhou MG, Wang HD, Zhu J, et al. Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet. 2016;387:251–72.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Report of Nutrition and Chronic Diseases in China. 2015.
  5. 5.
    Li LM, Rao KQ, Kong LZ, et al. A description on the Chinese national nutrition and health survey in 2002. Chin J Epidemiol. 2005;07:478–84.Google Scholar
  6. 6.
    Xi B, Liang Y, Reilly KH, et al. Trends in prevalence, awareness, treatment, and control of hypertension among Chinese adults 1991-2009. Int J Cardiol. 2012;158(2):326–9.PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Pan Y, Cai W, Cheng Q, et al. Association between anxiety and hypertension: a systematic review and meta-analysis of epidemiological studies. Neuropsychiatr Dis Treat. 2015;11:1121–30.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Survey on prevalence and risk factors for primary hypertension among communities in Changing District, Shanghai. Geriatr Health Care. 2012;18(1):19–22.Google Scholar
  9. 9.
    Wang JG, Li LH. Hypertension series: the differential diagnosis and treatment for secondary hypertension- continued. Chin Circ J. 2012;27(2):85–6.Google Scholar
  10. 10.
    Li NF, Wang L, Zhou KM, et al. Analysis of etiology of the patients with hypertension from the People’s Hospital of Xinjiang Uygur Autonomous Region. Chin J Cardiol. 2007;35(9):865–8.Google Scholar
  11. 11.
    Yang GH, Fan LX, Tan J, et al. Smoking in China: Findings of the 1996 National Prevalence Survey. JAMA. 1999;282(13):1247–53.PubMedCrossRefGoogle Scholar
  12. 12.
    Yang GH, Li Q, Hsia J. Prevalence of smoking in China in 2010. N Engl J Med. 2011;364(25):2469–70.PubMedCrossRefGoogle Scholar
  13. 13.
    Huang ZJ, Wang LM, Zhang M, et al. Smoking behavior among the Chinese employed floating population aged 18-59 in 2012. Chin J Epidemiol. 2014;35(11):1192–7.Google Scholar
  14. 14.
    Han J, Che XG. A meta-analysis of cigarette smoking prevalence among adolescents in China: 1981-2010. Int J Environ Res Public Health. 2015;12:4617–30.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Yang GH. Global Adult Tobacco Survey (GATS)-China Report. Beijing: Three-Gorgas Press; 2010, 2011.11.Google Scholar
  16. 16.
    Gu D, Kelly TN, Wu X, et al. Mortality attributable to smoking in China. N Engl J Med. 2009;360(2):150–9.PubMedCrossRefGoogle Scholar
  17. 17.
    He J, Gu D, Reynolds K, et al. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. Circulation. 2004;110(4):405–11.PubMedCrossRefGoogle Scholar
  18. 18.
    Yang WY, Xiao JZ, Yang ZJ, et al. Serum lipids and lipoproteins in Chinese men and women. Circulation. 2012;125:2212–21.PubMedCrossRefGoogle Scholar
  19. 19.
    Li JH, Mi SQ, Li YC, et al. The levels and distribution of serum lipids in Chinese adults, 2010. Chin J Prev Med. 2012;46(7):607–12.Google Scholar
  20. 20.
    Zhao WH, Zhang J, Li Y. Report of Chinese nutrition and health status: blood lipid 2002 [J]. People’s Medical Publishing House. 2002.Google Scholar
  21. 21.
    Ding WQ, Dong HB, Mi J, et al. Prevalence of dyslipidemia in Chinese children and adolescents: a Meta-analysis. Chin J Epidemiol. 2015;36(1):71–7.Google Scholar
  22. 22.
    Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310(9):948–58.PubMedCrossRefGoogle Scholar
  23. 23.
    An YL, Zhang P, Wang JP, et al. Cardiovascular and all-cause mortality over a 23-year period among Chinese with newly diagnosed diabetes in the Da Qing IGT and Diabetes Study. Diabetes Care. 2015;38(7):1365–71.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Li GW, Zhang P, Wang J, et al. Long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet. 2008;371:1783–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Gong Q, Gregg EW, Wang J, et al. Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study. Diabetologia. 2011;54(2):300–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Li GW, Zhang P, Wang JP, et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Lancet Diabetes Endocrinol. 2014;2(6):474–80.PubMedCrossRefGoogle Scholar
  27. 27.
    Ji L, Hu D, Pan C, et al. Primacy of the 3B approach to control risk factors for cardiovascular disease among type 2 diabetes. Am J Med. 2013;126(10):925e11–22.CrossRefGoogle Scholar
  28. 28.
    Ma GS, Li YP, Wu YF, et al. The prevalence of body weight and obesity and its change among Chinese people during 1992 to 2002. Chin J Prev Med. 2005;39(5):311–5.Google Scholar
  29. 29.
    Gordon Larsen P, Wang H, Popkin BM. Overweight dynamics in Chinese children and adults. Obes Rev. 2014;15(S1):37–48.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Li XY, Jiang Y, Hu N, et al. Prevalence and characteristic of overweight and obesity among adults in China, 2010. Chin J Prev Med. 2012;46(8):683–6.Google Scholar
  31. 31.
    Lao XQ, Ma WJ, Sobko T, et al. Overall obesity is leveling-off while abdominal obesity continues to rise in a Chinese population experiencing rapid economic development: analysis of serial cross-sectional health survey data 2002–2010. Int J Obes. 2015;39(2):288–94.CrossRefGoogle Scholar
  32. 32.
    Ma J, Cai XH, Wang HJ, et al. The trend analysis of overweight and obesity in Chinese students during 1985-2010. Chin J Prev Med. 2012;46(9):776–80.Google Scholar
  33. 33.
    Du HD Li LM, Whitlock G, et al. Patterns and socio-demographic correlates of domain-specific physical activities and their associations with adiposity in the China Kadoorie Biobank Study. BMC Public Health. 2014;14:826.CrossRefGoogle Scholar
  34. 34.
    Ng SW, Howard AG, Wang HJ, et al. The physical activity transition among adults in China: 1991–2011. Obes Rev. 2014;15(S1):27–36.PubMedCrossRefGoogle Scholar
  35. 35.
    Chen Y, Zheng Z, Yi J, et al. Associations between physical inactivity and sedentary behaviors among adolescents in 10 cities in China. BMC Public Health. 2014;14(1):744.PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Fan S, Chen J, Huang J, et al. Physical activity level and incident type 2 diabetes among Chinese adults. Med Sci Sports Exerc. 2015;47(4):751–6.PubMedCrossRefGoogle Scholar
  37. 37.
    Zhai FY, Yan XG. Survey Report on the Status of Nutrition and Health of the Chinese People in 2002: Series Two, Status of Diet and Nutrients consumption, vol. 7. Beijing: People’s Medical Publishing House; 2006.Google Scholar
  38. 38.
    Yu D, Zhang X, Xiang YB, et al. Adherence to dietary guidelines and mortality: a report from prospective cohort studies of 134,000 Chinese adults in urban Shanghai. Am J Clin Nutr. 2014;100(2):693–700.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Yu D, Zhang X, Gao YT, et al. Fruit and vegetable intake and risk of CHD: results from prospective cohort studies of Chinese adults in Shanghai. Br J Nutr. 2014;111(2):353–62.PubMedCrossRefGoogle Scholar
  40. 40.
    Du S, Neiman A, Batis C, et al. Understanding the patterns and trends of sodium intake, potassium intake, and sodium to potassium ratio and their effect on hypertension in China. Am J Clin Nutr. 2014;99(2):334–43.PubMedCrossRefGoogle Scholar
  41. 41.
    Brook RD, Rajagopalan S, Pope CA 3rd, et al. Particulate matter air matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation. 2010;121(21):2331–78.PubMedCrossRefGoogle Scholar
  42. 42.
    Kan H, London SJ, Chen G, et al. Differentiating the effects of fine and coarse particles on daily mortality in Shanghai, China. Environ Int. 2007;33:376–84.PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Huang W, Cao J, Tao Y, et al. Seasonal variation of chemical species associated with short-term mortality effects of PM(2.5) in Xi’an, a Central City in China. Am J Epidemiol. 2012;175(6):556–66.PubMedPubMedCentralCrossRefGoogle Scholar
  44. 44.
    Zhao K, Cao JY, Wen XM. Correlation between PM2.5 pollution in air and mortality of residents in urban area, Xi’an. [Chinese]. J Prev Med Inf. 2011;27(4):257–62.Google Scholar
  45. 45.
    Ma Y, Chen R, Pan G, et al. Fine particulate air pollution and daily mortality in Shenyang, China. Sci Total Environ. 2011;409:2473–7.PubMedCrossRefGoogle Scholar
  46. 46.
    Yang C, Peng X, Huang W, et al. A time-stratified case-crossover study of fine particulate matter air pollution and mortality in Guangzhou, China. Int Arch Occup Environ Health. 2012;85(5):579–85.PubMedCrossRefGoogle Scholar
  47. 47.
    Dai J, Chen R, Meng X, et al. Ambient air pollution, temperature and out-of-hospital coronary deaths in Shanghai, China. Environ Pollut. 2015;203:116–21.CrossRefGoogle Scholar
  48. 48.
    Xie W, Li G, Zhao D, et al. Relationship between fine particulate air pollution and ischaemic heart disease morbidity and mortality. Heart. 2015;101:257–63.PubMedCrossRefGoogle Scholar
  49. 49.
    National Health and Family Planning Commission of the People’s Republic of China. China Health and Family Planning Statistics Yearbook. Beijing: Peking Union Medical College Press; 2015.Google Scholar
  50. 50.
    Cao J, Yang C, Li J, et al. Association between long-term exposure to outdoor air pollution and mortality in China: a cohort study. J Hazard Mater. 2011;186:1594–600.PubMedCrossRefGoogle Scholar
  51. 51.
    Wang Y, Zhao X, Jiang Y, et al. Prevalence, knowledge, and treatment of transient ischemic attacks in China. Neurology. 2015;84(23):2354–61.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Ministry of Health Statistics Center. 2008 China health services survey – 4th Family health survey. China Statistics Press. 2009.Google Scholar
  53. 53.
    Gu DF, Huang GY, He J, et al. Investigation of prevalence and distributing feature of chronic heart failure in Chinese adult population. Chin J Cardiol. 2003;31(1):3–6.Google Scholar
  54. 54.
    Zhang J, Zhang YH, et al. China heart failure registry study–a multicenter, prospective investigation for preliminary analysis on etiology, clinical features and treatment in heart failure patients. Chin Circ J. 2015;30(5):413–6.Google Scholar
  55. 55.
    Ministry of Health of People’s Republic of China. National health statistics annual report 1980–2001 [J], vol. 01: China Statistics Press; 1985. p. 56.Google Scholar
  56. 56.
    Ministry of Health of People’s Republic of China. China health statistics yearbook [J]. China Statistics Press. 2002–2012.Google Scholar
  57. 57.
    National Health and Family Planning Commission of the People’s Republic of China. China statistical yearbook of health and family planning [J]. Beijing: People’s Medical Publishing House; 2013–2015.Google Scholar
  58. 58.
    He D, Yu H, Chen Y. Equity in the distribution of CT and MRI in China: a panel analysis. Int J Equity Health. 2013;12:39.PubMedPubMedCentralCrossRefGoogle Scholar
  59. 59.
    Oh E-H, Imanaka Y, Evans E. Determinants of the diffusion of computed tomography and magnetic resonance imaging. Int J Technol Assess Health Care. 2005;21:73–80.PubMedCrossRefGoogle Scholar
  60. 60.
    Ma J, Lu M, Quan H. From a national, centrally planned health system to a system based on the market: lessons from China. Health Aff (Millwood). 2008;27:937–48.CrossRefGoogle Scholar
  61. 61.
    X-ray computed tomography. Wikipedia 2012.
  62. 62.
    Liu K, Hsieh C, Zhuang N, Gao Y, Li ZN, Ren XS, Yang L, Zhang JY, Budoff MJ, Lu B. Current utilization of cardiac computed tomography in mainland China: a national survey. J Cardiovasc Comput Tomogr. 2016;10(1):76–81. PMID26699712.CrossRefGoogle Scholar
  63. 63.
    Maurer MH, Hamm B, Dewey M. Survey regarding the clinical practice of cardiac CT in Germany: indications, scanning technique and reporting. RöFo. 2009;181:1135e1143.Google Scholar
  64. 64.
    Leipsic J, Abbara S, Achenbach S, et al. SCCT guidelines for the interpretation and reporting of coronary CT angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee. J Cardiovasc Comput Tomogr. 2014;8:342–58.PubMedPubMedCentralCrossRefGoogle Scholar
  65. 65.
    Kim YJ, Yong HS, Kim SM, Kim JA, Yang DH, Hong YJ. Korean guidelines for the appropriate use of cardiac CT. Korean J Radiol. 2015;16:251–85.PubMedPubMedCentralCrossRefGoogle Scholar
  66. 66.
    Muhlestein JB, Lappe DL, Lima JA, et al. Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial. JAMA. 2014;312:2234–43.PubMedPubMedCentralCrossRefGoogle Scholar
  67. 67.
    Blumenthal D, Hsiao W. Lessons from the East—China’s rapidly evolving health care system. N Engl J Med. 2015;372:1281–5.PubMedCrossRefGoogle Scholar
  68. 68.
    Hausleiter J, Meyer T, Hermann F, et al. Estimated radiation dose associated with cardiac CT angiography. JAMA. 2009;301:500–7.CrossRefGoogle Scholar
  69. 69.
    Stehli J, Fuchs TA, Bull S, et al. Accuracy of coronary CT angiography using a submillisievert fraction of radiation exposure: comparison with invasive coronary angiography. J Am Coll Cardiol. 2014;64:772–80.PubMedPubMedCentralCrossRefGoogle Scholar
  70. 70.
    Zhao L, Plank F, Kummann M, et al. Improved non-calcified plaque delineation on coronary CT angiography by sonogram-affirmed iterative reconstruction with different filter strength and relationship with BMI. Cardiovasc Diagn Ther. 2015;5:104–12.PubMedPubMedCentralGoogle Scholar
  71. 71.
    Schindera ST, Treier R, von Allmen G, et al. An education and training programme for radiological institutes: impact on the reduction of the CT radiation dose. Eur Radiol. 2011;21:2039–45.PubMedCrossRefGoogle Scholar
  72. 72.
    Garcia MJ, Blankstein R, Budoff MJ, et al. COCATS 4 Task Force 7: Training in Cardiovascular Computed Tomographic Imaging. J Am Coll Cardiol. 2015;65:1810–21.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Humana Press 2019

Authors and Affiliations

  • Bin Lu
    • 1
  • Weihua Yin
    • 1
  • Xinshuang Ren
    • 1
  • Siyu Chen
    • 1
  1. 1.Department of Radiologic ImagingFuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Center of Cardiovascular DiseasesBeijingChina

Personalised recommendations